» Articles » PMID: 2594913

Nicotine Maintains Robust Self-administration in Rats on a Limited-access Schedule

Overview
Specialty Pharmacology
Date 1989 Jan 1
PMID 2594913
Citations 235
Authors
Affiliations
Soon will be listed here.
Abstract

Intravenous nicotine maintained substantial responding on the drug-reinforced lever with a limited-access, fixed-ratio 5 schedule of self-administration. Responding demonstrated the expected pharmacological sensitivity; it was dose-dependently reduced by pre-session treatment with either nicotine or mecamylamine but not with hexamethonium. In addition, responding was dependent on the size of the unit dose, with maximum values occurring at 0.01 and 0.03 mg/kg/infusion. Self-administration behavior decreased at doses both above and below these, and extinction followed the substitution of saline for nicotine. Total session drug intake increased with unit dose up to a maximal value of approximately 0.5 mg/kg at 0.03 mg/kg/infusion, but did not increase further at the 0.06 mg/kg/infusion dose. A decrease in the time-out duration at the dose of 0.03 mg/kg/infusion also did not change the total session intake of nicotine. It is suggested that nicotine intake is controlled both by the total amount of drug obtained and by the magnitude of the unit dose. These results demonstrate that intravenous nicotine can maintain substantial self-administration behavior in rodents.

Citing Articles

Pavlovian conditioning with the internal stimulus effects of intravenous nicotine heightens later nicotine taking with variation by dose and sex.

Barrett S, McNealy K, Ramirez H, Flynn A, Bevins R Sci Rep. 2025; 15(1):5500.

PMID: 39952959 PMC: 11829035. DOI: 10.1038/s41598-024-84145-1.


Sex differences in nicotine intake and relapse behavior in nicotine-dependent adult wistar rats.

Chellian R, Behnood-Rod A, Bruijnzeel A Front Pharmacol. 2024; 15:1415219.

PMID: 39391691 PMC: 11464435. DOI: 10.3389/fphar.2024.1415219.


Enhancing translation: A need to leverage complex preclinical models of addictive drugs to accelerate substance use treatment options.

Corley C, Craig A, Sadek S, Marusich J, Chehimi S, White A Pharmacol Biochem Behav. 2024; 243():173836.

PMID: 39067531 PMC: 11344688. DOI: 10.1016/j.pbb.2024.173836.


Fluorocitrate inhibition of astrocytes reduces nicotine self-administration and alters extracellular levels of glutamate and dopamine within the nucleus accumbens in male wistar rats.

Tan X, Neslund E, Fentis K, Ding Z Neuropharmacology. 2024; 255:110001.

PMID: 38750804 PMC: 11156530. DOI: 10.1016/j.neuropharm.2024.110001.


N-oleoyl alanine attenuates nicotine reward and spontaneous nicotine withdrawal in mice.

Karin K, Mustafa M, Poklis J, Buzzi B, Schlosburg J, Parker L Drug Alcohol Depend. 2024; 259:111276.

PMID: 38676968 PMC: 11325338. DOI: 10.1016/j.drugalcdep.2024.111276.


References
1.
Cox B, Goldstein A, Nelson W . Nicotine self-administration in rats. Br J Pharmacol. 1984; 83(1):49-55. PMC: 1987179. DOI: 10.1111/j.1476-5381.1984.tb10118.x. View

2.
Singer G, Simpson F, Lang W . Schedule induced self injections of nicotine with recovered body weight. Pharmacol Biochem Behav. 1978; 9(3):387-9. DOI: 10.1016/0091-3057(78)90302-7. View

3.
Collins R, Weeks J, Cooper M, Good P, Russell R . Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berl). 1984; 82(1-2):6-13. DOI: 10.1007/BF00426372. View

4.
Yokel R, Wise R . Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science. 1975; 187(4176):547-9. DOI: 10.1126/science.1114313. View

5.
Goldberg S, Spealman R, Goldberg D . Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science. 1981; 214(4520):573-5. DOI: 10.1126/science.7291998. View